Celgene, Dr Reddy's abandon cancer drug patent dispute
01-02-2022
Teva urges Fed Circuit to save skinny label law from ‘nullification’
03-12-2020
Teva withdraws Shield patent oppositions
19-10-2020
Fed Circuit reinstates $235m verdict against Teva
06-10-2020
Teva charged in DoJ antitrust probe into generic drug price-fixing
26-08-2020
Shkreli inflated price of life-saving drug from federal prison, FTC says
14-08-2020